Chemicals•Mid Cap
Clear visual breakdown: for every ₹100 earned, see how much flows to salaries, operating costs, government taxes, EPS profit, and your share.
Moderate volume margin
Workforce salaries, engineers & talent
Annual profit generated per stock unit
Direct cash dividends & buybacks
Select or type any investment amount to see how much commercial activity and earnings your money commands in ARCHEAN CHEMICAL IND LTD.
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for use as a water-soluble fertiliser in agricultural applications. Archean Chemical Industries Limited was founded in 2003 and is based in Chennai, India.
Comparing ARCHEAN CHEMICAL IND LTD with leading competitors in Chemicals (Indian Market)
| # | Company Name | CMP | 1D % | P/E | Market Cap | Div Yield | 1Y Return |
|---|---|---|---|---|---|---|---|
| 1 | PIDILITE INDUSTRIES LTD(PIDILITIND) | ₹1,579.00 | +1.63% | 60.9 | ₹1,60,827 Cr | 0.73% | +6.79% |
| 2 | SRF LTD(SRF) | ₹2,460.40 | -0.99% | 31.6 | ₹72,928 Cr | 0.41% | -14.22% |
| 3 | AETHER INDUSTRIES LIMITED(AETHER) | ₹1,561.80 | +0.61% | 83.3 | ₹20,731 Cr | 0.00% | +110.87% |
| 4 | ARCHEAN CHEMICAL IND LTDCurrent | ₹416.40 | -1.95% | 50.3 | ₹5,141 Cr | 0.60% | -33.08% |
| 5 | ANDHRA PAPER LIMITED(ANDHRAPAP) | ₹61.52 | -1.96% | 23.4 | ₹1,223 Cr | 0.81% | -14.79% |
| 6 | BOMBAY SUPER HYBRID SEEDS(BSHSL) | ₹90.80 | +6.24% | 35.1 | ₹953 Cr | 0.00% | -28.37% |
Quotes are delayed by at least 15 minutes. Financial metrics and disclosures are cross-referenced with periodic statutory disclosures from the National Stock Exchange of India (NSE) and BSE India. This content is provided strictly for educational and portfolio analytics purposes, and does not constitute investment advice or Buy/Sell recommendations.